ARTICLE | Clinical News
Oral calcitonin: Began Phase I testing
January 4, 2000 8:00 AM UTC
Unigene Inc. (UGNE), Fairfield, N.J. Product: Oral calcitonin Business: Musculoskeletal Therapeutic category: Drug delivery, Hormone replacement Target: Osteoclasts Description: Osteoclast inhibitor ...